Skip to main content
January 8, 2025: MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment – Endpoints News
Media

January 8, 2025: MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment – Endpoints News

Date : 08/01/2025

MaaT Pharma
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

 MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club